- Report
- May 2024
- 68 Pages
Africa, Middle East
From €2746EUR$2,950USD£2,296GBP
- Report
- May 2024
- 173 Pages
Global
From €4607EUR$4,950USD£3,853GBP
- Report
- November 2023
- 430 Pages
Global
From €2327EUR$2,500USD£1,946GBP
- Report
- July 2023
- 332 Pages
United States
From €7441EUR$7,995USD£6,223GBP
- Drug Pipelines
- December 2022
- 127 Pages
Global
From €13956EUR$14,995USD£11,671GBP
- Report
- July 2022
- 161 Pages
Global
From €1861EUR$2,000USD£1,557GBP
- Report
- March 2022
- 97 Pages
Global
From €3500EUR$4,028USD£3,030GBP
- Report
- August 2024
- 99 Pages
Global
From €3500EUR$4,028USD£3,030GBP
- Report
- May 2026
- 108 Pages
United States
From €4649EUR$4,995USD£3,888GBP
- Report
- May 2022
- 226 Pages
Global
From €2327EUR$2,500USD£1,946GBP
- Book
- November 2024
North America

Endometriosis is a condition in which the tissue that normally lines the uterus grows outside of the uterus, most commonly on the ovaries, fallopian tubes, and the tissue lining the pelvis. It is a common condition among women of reproductive age, and can cause pain, heavy menstrual bleeding, and infertility. Endometriosis is often treated with hormone therapy, surgery, or a combination of both.
The Endometriosis market within the context of Women's Health is a growing field, with a focus on providing treatments and therapies to improve the quality of life for those affected. Companies in this market are developing new treatments and therapies to address the symptoms of endometriosis, as well as researching new ways to diagnose and manage the condition.
Some companies in the Endometriosis market include AbbVie, Bayer, Allergan, and Myovant Sciences. Show Less Read more